Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ATAI
8776
DELISTED
AtaiBeckley Inc
ATAI
| $607K | ﹤0.01% |
171,388
-1,370,118
| -89% | -$5.16M |
2024 Q4
5 quarters
|
|
8777
CALL
Chesapeake Utilities
CPK
$3.23B
| $607K | ﹤0.01% |
4,800
-2,000
| -29% | -$258K |
2025 Q3
2 quarters
|
|
8778
Invesco RAFI Strategic US ETF
IUS
$977M
| $607K | ﹤0.01% |
10,473
-2,769
| -21% | -$164K |
2025 Q4
1 quarter
|
|
8779
CALL
Vanguard Consumer Staples ETF
VDC
$7.64B
| $606K | ﹤0.01% |
+2,700
| New | +$618K |
2026 Q1
0 quarters
|
|
8780
WisdomTree US SmallCap Earnings Fund
EES
$684M
| $606K | ﹤0.01% |
+10,446
| New | +$617K |
2026 Q1
0 quarters
|
|
8781
PUT
Graphic Packaging
GPK
$2.53B
| $606K | ﹤0.01% |
61,000
+36,500
| +149% | +$460K |
2021 Q4
17 quarters
|
|
8782
Nuvectis Pharma
NVCT
$669M
| $606K | ﹤0.01% |
+78,425
| New | +$672K |
2026 Q1
0 quarters
|
|
8783
PUT
Arcutis Biotherapeutics
ARQT
$3.03B
| $605K | ﹤0.01% |
25,700
-8,200
| -24% | -$209K |
2022 Q4
13 quarters
|
|
|
HDRN
8784
Hadron Energy
HDRN
$82.9M
| $605K | ﹤0.01% |
56,804
-697,496
| -92% | -$7.39M |
2025 Q4
1 quarter
|
|
8785
PUT
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$265M
| $605K | ﹤0.01% |
60,800
+5,300
| +10% | +$50.5K |
2023 Q4
9 quarters
|
|
8786
iShares Self-Driving EV and Tech ETF
IDRV
$263M
| $605K | ﹤0.01% |
15,696
-245,137
| -94% | -$9.52M |
2024 Q4
5 quarters
|
|
|
ESPR
8787
CALL
DELISTED
Esperion Therapeutics
ESPR
| $605K | ﹤0.01% |
220,700
-131,000
| -37% | -$415K |
2017 Q1
36 quarters
|
|
8788
PUT
Janux Therapeutics
JANX
$1.06B
| $605K | ﹤0.01% |
43,500
-40,300
| -48% | -$553K |
2022 Q4
13 quarters
|
|
8789
CALL
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$26.3M
| $603K | ﹤0.01% |
38,000
-9,400
| -20% | -$128K |
2024 Q1
8 quarters
|
|
8790
CALL
Arhaus
ARHS
$1.38B
| $603K | ﹤0.01% |
89,000
-22,100
| -20% | -$201K |
2022 Q2
15 quarters
|
|
8791
CALL
Cullen/Frost Bankers
CFR
$9.33B
| $603K | ﹤0.01% |
4,400
-2,500
| -36% | -$345K |
2013 Q2
51 quarters
|
|
|
AGIX
8792
KraneShares Public-Private AI & Technology ETF
AGIX
$1.17B
| $603K | ﹤0.01% |
18,402
+7,885
| +75% | +$275K |
2025 Q4
1 quarter
|
|
8793
Invesco S&P SmallCap Financials ETF
PSCF
$27.5M
| $603K | ﹤0.01% |
10,605
+2,388
| +29% | +$141K |
2025 Q4
1 quarter
|
|
|
IONX
8794
CALL
Defiance Daily Target 2X Long IONQ ETF
IONX
$161M
| $602K | ﹤0.01% |
28,980
+13,547
| +88% | +$605K |
2025 Q4
1 quarter
|
|
8795
PUT
Altimmune
ALT
$529M
| $602K | ﹤0.01% |
195,600
-382,900
| -66% | -$1.63M |
2020 Q1
24 quarters
|
|
8796
CALL
VanEck Retail ETF
RTH
$239M
| $602K | ﹤0.01% |
+2,400
| New | +$622K |
2026 Q1
0 quarters
|
|
|
EQLT
8797
iShares MSCI Emerging Markets Quality Factor ETF
EQLT
$12.4M
| $602K | ﹤0.01% |
18,915
-56,947
| -75% | -$1.86M |
2024 Q3
6 quarters
|
|
8798
Genasys
GNSS
$65.6M
| $602K | ﹤0.01% |
330,834
+114,706
| +53% | +$227K |
2024 Q3
6 quarters
|
|
8799
PUT
UDR
UDR
$10.7B
| $601K | ﹤0.01% |
17,800
-16,700
| -48% | -$613K |
2022 Q4
13 quarters
|
|
|
WLTH
8800
CALL
Wealthfront Corp
WLTH
$1.69B
| $601K | ﹤0.01% |
+65,000
| New | +$594K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.